These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33648972)

  • 1. Acute Kidney Injury, Microvascular Rarefaction, and Estimated Glomerular Filtration Rate in Kidney Transplant Recipients.
    Doreille A; Azzi F; Larivière-Beaudoin S; Karakeussian-Rimbaud A; Trudel D; Hébert MJ; Dieudé M; Patey N; Cardinal H
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):415-426. PubMed ID: 33648972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of peritubular capillary density with glomerular volume and kidney function in living kidney donors.
    van der Weijden J; De Hoogt PA; Leufkens MME; Keijbeck AA; van Goor H; van den Heuvel MC; Cleutjens JPM; Moers C; Snoeijs MG; Navis GJ; van Londen M; Nolte IM; Berger SP; De Borst MH; Peutz-Kootstra CJ
    J Nephrol; 2023 Sep; 36(7):2111-2124. PubMed ID: 37768545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury.
    Lan S; Yang B; Migneault F; Turgeon J; Bourgault M; Dieudé M; Cardinal H; Hickey MJ; Patey N; Hébert MJ
    Am J Physiol Renal Physiol; 2021 Sep; 321(3):F335-F351. PubMed ID: 34338031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy.
    Basile DP
    Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):1-7. PubMed ID: 15090853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Wewers TM; Mayer AB; Pfleiderer A; Beul K; Schmidt R; Heitplatz B; Van Marck V; Nolte I; Pavenstädt H; Reuter S; Brand M; Di Marco GS
    Kidney Int; 2019 May; 95(5):1091-1102. PubMed ID: 30824181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice.
    Kramann R; Tanaka M; Humphreys BD
    J Am Soc Nephrol; 2014 Sep; 25(9):1924-31. PubMed ID: 24652794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human adipose stromal cell therapy improves survival and reduces renal inflammation and capillary rarefaction in acute kidney injury.
    Collett JA; Traktuev DO; Mehrotra P; Crone A; Merfeld-Clauss S; March KL; Basile DP
    J Cell Mol Med; 2017 Jul; 21(7):1420-1430. PubMed ID: 28455887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Kidney Injury in Children with Kidney Transplantation.
    Alkandari O; Nguyen L; Hebert D; Langlois V; Jawa NA; Parekh RS; Robinson LA
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1721-1729. PubMed ID: 30242029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function.
    Heilman RL; Smith ML; Smith BH; Qaqish I; Khamash H; Singer AL; Kaplan B; Reddy KS
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2225-2232. PubMed ID: 27797897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the donor pool in kidney transplantation: Should organs with acute kidney injury be accepted?-A retrospective study.
    Schütte-Nütgen K; Finke M; Ehlert S; Thölking G; Pavenstädt H; Suwelack B; Palmes D; Bahde R; Koch R; Reuter S
    PLoS One; 2019; 14(3):e0213608. PubMed ID: 30865677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deceased-donor acute kidney injury is not associated with kidney allograft failure.
    Hall IE; Akalin E; Bromberg JS; Doshi MD; Greene T; Harhay MN; Jia Y; Mansour SG; Mohan S; Muthukumar T; Reese PP; Schröppel B; Singh P; Thiessen-Philbrook HR; Weng FL; Parikh CR
    Kidney Int; 2019 Jan; 95(1):199-209. PubMed ID: 30470437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
    Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal allograft C4d deposition in Chinese: Hong Kong perspective.
    Yuen SK; Mak YF; Tang HL; Yong SP; Chow KM; Chu KH; Fung KS; Chan WH; Tong KL
    Nephrology (Carlton); 2008 Jun; 13(3):256-63. PubMed ID: 18315707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
    Huang E; Vo A; Choi J; Ammerman N; Lim K; Sethi S; Kim I; Kumar S; Najjar R; Peng A; Jordan SC
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):109-116. PubMed ID: 31843975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
    Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
    Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary rarefaction: a missing link in renal and cardiovascular disease?
    Steegh FMEG; Keijbeck AA; de Hoogt PA; Rademakers T; Houben AJHM; Reesink KD; Stehouwer CDA; Daemen MJAP; Peutz-Kootstra CJ
    Angiogenesis; 2024 Feb; 27(1):23-35. PubMed ID: 37326760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Deceased Donor Acute Kidney Injury With Recipient Graft Survival.
    Liu C; Hall IE; Mansour S; Thiessen Philbrook HR; Jia Y; Parikh CR
    JAMA Netw Open; 2020 Jan; 3(1):e1918634. PubMed ID: 31913491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney Function.
    Siew ED; Abdel-Kader K; Perkins AM; Greevy RA; Parr SK; Horner J; Vincz AJ; Denton J; Wilson OD; Hung AM; Robinson-Cohen C; Matheny ME
    Am J Kidney Dis; 2020 Feb; 75(2):204-213. PubMed ID: 31537394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.